What Boswellia Does in Your Body

Boswellia is a resin extracted from the bark of Boswellia trees, native to India, Somalia, and the Arabian Peninsula. The active compounds—called boswellic acids—appear to reduce inflammation by blocking molecules your immune system uses to trigger inflammatory responses. The most studied boswellic acid, AKBA (acetyl-11-keto-beta-boswellic acid), seems to inhibit an enzyme called 5-lipoxygenase, which your body uses to produce inflammatory signaling chemicals called leukotrienes.

Unlike NSAIDs such as ibuprofen, which block pain broadly across multiple pathways, boswellia targets a narrower set of inflammatory mechanisms. This is why some people turn to it as an alternative when they want to avoid long-term NSAID use or when NSAIDs have caused side effects. The resin has been used in Ayurvedic and traditional medicine for centuries, but the modern research into its mechanism is relatively recent—most human trials have been conducted in the last 20 years.

Key Takeaways

  • Boswellia contains boswellic acids that block inflammatory pathways in your body, particularly the production of leukotrienes.
  • Human trials show modest benefits for joint pain and mobility in people with osteoarthritis and rheumatoid arthritis, though effects are smaller than prescription anti-inflammatory drugs.
  • Most research uses standardized extracts containing 30–65% boswellic acids, and doses in studies range from 300 to 1,000 mg daily.
  • Boswellia is generally well tolerated, but it can interact with blood thinners and may cause digestive upset in some people.
  • The evidence is strongest for joint conditions; claims about gut inflammation, asthma, or cancer remain preliminary and based mainly on animal or lab studies.

What Human Research Shows for Joint Pain

The most robust evidence for boswellia comes from studies on osteoarthritis and rheumatoid arthritis. A 2014 systematic review in Phytotherapy Research examined multiple randomized controlled trials and found that boswellia reduced joint pain and improved function in people with knee osteoarthritis, with effects comparable to some conventional treatments but generally smaller than prescription NSAIDs or corticosteroids.

One frequently cited trial gave 60 people with knee osteoarthritis either 333 mg of boswellia extract three times daily or placebo for 8 weeks. The boswellia group showed greater reductions in pain and swelling and improved walking distance compared to placebo. However, the improvement was modest—pain scores dropped by roughly 35% in the boswellia group versus 10% in placebo. Similar patterns appear in trials for rheumatoid arthritis, where boswellia reduced joint swelling and morning stiffness but did not halt disease progression.

The gap between boswellia and prescription anti-inflammatory drugs matters. If you have severe inflammatory arthritis, boswellia alone is unlikely to replace medical treatment. For mild to moderate joint discomfort or as an add-on to existing therapy, the evidence suggests it may offer some relief, though individual responses vary widely.

Dosage, Extract Quality, and How Long It Takes

Most human studies use standardized boswellia extracts containing 30–65% boswellic acids, with daily doses ranging from 300 to 1,000 mg split across two or three doses. The variation matters because boswellia resin in its raw form contains only 5–10% boswellic acids, so a standardized extract is far more concentrated and consistent than whole resin powder.

Effects are not when ready. In the osteoarthritis trials, meaningful pain reduction typically appeared after 4 to 8 weeks of daily use. Some people report changes within 2 to 3 weeks; others see no benefit even after 12 weeks. This delayed onset is consistent with how boswellia works—it is modulating inflammatory pathways rather than blocking pain acutely the way an NSAID does.

When buying boswellia supplements, look for products that specify the percentage of boswellic acids and the extract type. Extracts labeled "standardized to 65% boswellic acids" or similar are more reliable than products listing only "boswellia resin" without standardization. Supplement quality varies by manufacturer, and third-party testing through organizations like USP or NSF can help confirm what is actually in the bottle.

Claims Beyond Joint Health: What the Evidence Actually Shows

Boswellia is marketed for inflammatory bowel conditions, asthma, and even cancer prevention. The evidence for these uses is much weaker. Most studies are in animals or isolated cells, not humans. A small human trial found boswellia reduced symptoms in people with ulcerative colitis, but the study was small and not well-controlled. For asthma, one trial showed modest improvements in lung function, but again, the evidence is limited and not strong enough to recommend boswellia as a primary treatment.

Cancer claims are particularly important to address clearly: laboratory studies show boswellic acids can slow growth of certain cancer cell lines in a dish, but this does not mean boswellia prevents or treats cancer in humans. No human trials have tested whether boswellia reduces cancer risk or improves outcomes in cancer patients. If you have cancer or are at high risk, boswellia should not replace proven medical care, and you should discuss any supplement use with your oncologist because of potential interactions.

Side Effects and Drug Interactions

Boswellia is generally well tolerated. The most common side effects reported in trials are mild digestive complaints—nausea, heartburn, or loose stools—occurring in roughly 5–10% of people taking it. These usually resolve if you take boswellia with food or reduce the dose.

The main interaction concern is with blood thinners. Boswellia may have mild anticoagulant properties, meaning it could theoretically increase bleeding risk if combined with warfarin, apixaban, or other anticoagulants. The evidence for this interaction is limited, but it is serious enough that you should inform your doctor if you take blood thinners and want to use boswellia. Similarly, if you are scheduled for surgery, mention boswellia use beforehand because of the theoretical bleeding risk.

Boswellia may also interact with certain immunosuppressant medications used in rheumatoid arthritis treatment, though the clinical significance is unclear. If you take any prescription medications, especially for blood clotting or immune function, check with your pharmacist or doctor before starting boswellia.

How Boswellia Compares to Other Anti-Inflammatory Herbs

Within the anti-inflammatory herb category, boswellia stands out because it has the most human trial data and the clearest mechanism of action. Turmeric (curcumin) has similarly strong evidence for joint pain, though the two work through slightly different pathways—curcumin blocks NF-kappa B signaling, while boswellia targets 5-lipoxygenase. Some people find one more effective than the other; some benefit from using both together, though no large trials have directly compared them.

Ginger has weaker evidence than boswellia for joint pain, though it is well tolerated and inexpensive. Frankincense (another name for boswellia resin) and myrrh are sometimes used together in traditional medicine, but myrrh has minimal human research. If you are choosing between anti-inflammatory herbs, boswellia and turmeric have the strongest evidence bases for joint conditions, while ginger is a reasonable lower-cost option if you want to start with something gentler.

Who Might Benefit and Who Should Be Cautious

Boswellia may be worth trying if you have mild to moderate joint pain from osteoarthritis or rheumatoid arthritis and want to avoid or reduce reliance on NSAIDs, or if you have had side effects from NSAIDs. It is not a replacement for medical treatment of inflammatory arthritis, but it can be a useful addition to a treatment plan. Give it at least 4 to 8 weeks at a consistent dose before deciding whether it is working for you.

Be cautious or avoid boswellia if you take blood thinners, are pregnant or breastfeeding (safety data is limited), or have a bleeding disorder. If you have inflammatory bowel disease, asthma, or cancer, do not use boswellia as a substitute for medical care. Discuss it with your doctor first, especially if you take other medications.

Frequently Asked Questions

How long does it take to feel boswellia working?

Most people who benefit from boswellia notice changes after 4 to 8 weeks of daily use. Some report improvement within 2 to 3 weeks, while others see no change even after 12 weeks. If you do not notice any difference after 8 to 12 weeks at a consistent dose, it may not work for you.

Can I take boswellia with ibuprofen or other NSAIDs?

Yes, but combining them is usually unnecessary. If you are taking NSAIDs for pain, boswellia is meant as an alternative or add-on, not a duplicate therapy. Talk to your doctor about whether using both makes sense for your situation, especially if you are taking NSAIDs long-term.

Is boswellia safe to take every day?

Yes, boswellia is safe for long-term daily use in most people, based on the trials conducted so far. The longest studies ran for several months with no serious adverse effects. However, if you have a bleeding disorder or take blood thinners, check with your doctor first.

Does boswellia actually reduce inflammation, or just mask pain?

Boswellia appears to reduce inflammation itself by blocking the production of inflammatory molecules, not just numbing pain. This is why it takes longer to work than NSAIDs—it is addressing the underlying inflammatory process rather than blocking pain signals acutely.

What is the difference between boswellia and frankincense?

Frankincense is the resin from boswellia trees in its raw or minimally processed form. Boswellia supplements are usually standardized extracts of that resin, concentrated to contain a specific percentage of boswellic acids. Standardized extracts are more consistent and potent than raw frankincense resin.